Long-term consequences of cancer therapy: cognitive impairment following CAR T cell therapy
Saved in:
| Main Authors: | Kathrin Gabriel, Sebastian Kobold |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02324-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy
by: C. Carcopino, et al.
Published: (2024-12-01) -
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
by: Yok-Lam Kwong, et al.
Published: (2025-03-01) -
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer
by: Chuan Jin, et al.
Published: (2016-05-01) -
Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis
by: Sebastian Kobold, et al.
Published: (2025-06-01) -
Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution
by: Andreas Riedel, et al.
Published: (2025-07-01)